Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsiCare Part D transition coverage & prior auth | Op…
    Ask Trek AI about this page
    CurrentIntegrated Home Care Services (iCare)Policy N/A

    2026 Transition Policy for iCare Prescription Drug Coverage

    Customize your policy alerts

    Sign up for all integrated_home_care_services policy alerts

    Know when integrated_home_care_services releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines how Independent Care Health Plan (iCare) provides temporary transition supplies of Medicare Part D drugs for new and existing members during plan changes, treatment setting changes, and long-term care placements, and explains member notices, exceptions, and appeals procedures.

    Policy Summary
    PayerIntegrated Home Care Services (iCare)
    Policy2026 Transition Policy for iCare Prescription Drug Coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review DateN/A
    Key ActionSubmit clinical documentation or a letter explaining medical necessity when requesting an exception or prior authorization for transition supplies.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    30 daysstandard transition supply
    31 daysLTC / setting-change supply
    90 daysinitial period
    108 daysclaim history minimum

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    180 dayslookback
    3 business daysnotice timeframe

    Transition Supply Coverage Criteria

    Transition Supply Criteria

    Covered when ALL of the following apply for the specific member scenario

    New or existing member (standard): During the first 90 days as a member, iCare will cover a 30-day supply of a Medicare Part D drug one time per drug (multiple fills allowed to total 30 days if prescription written for <30 days).90 days/30 days

    One-time per drug during initial 90-day period; supports multiple partial fills to reach total supply.

    New member in long-term care: During the first 90 days for new members in long-term care with Medicare and full Medicaid, iCare will cover a 31-day supply of a Part D drug (multiple fills allowed to reach 31 days if prescription written for <31 days). After that, a 31-day emergency supply may be provided while exception/prior authorization is reviewed.90 days/31 days

    Applies when member is new to plan and in long-term care; exceptions/appeals processes available.

    Change in treatment setting: When a member changes treatment settings (e.g., hospital ↔ home, skilled nursing transfers, change from Part A to Part D coverage), iCare will cover up to a 31-day supply at a pharmacy; multiple changes in same month may require an exception/prior authorization and clinical review for harm from changing treatment plan.31 days

    Clinical review will assess treatment plan and potential harm from changing regimen.

    Brand-new drugs and history determination: Transition procedures apply to brand-new drugs not on the approved drug list or drugs with limits when iCare cannot distinguish brand-new use from ongoing history at point of sale; member must have ≥108 days of claim history and iCare will look back 180 days to determine prior use.≥108 days prior claims; 180-day lookback

    Used to decide whether transition supply or standard coverage applies.

    Transition supply is not available when plan coverage determination between Medicare Part A/B versus Part D is required, when a drug may be ineligible for Part D until the indication is known, or when additional information is needed to confirm safe use. These exceptions mean a temporary transition fill will not be provided until the coverage pathway or safety information is resolved.

    Initial Transition Fills for New Members

    Initial transition supplies

    Initial transition fills for new members

    Standard new member transition: Cover a 30-day supply of a Medicare Part D drug during the first 90 days of membership (one time per drug).
    New LTC member transition: Cover a 31-day supply during first 90 days for new members in long-term care with Medicare and full Medicaid; multiple fills allowed to reach total if <31-day prescriptions.

    Continuation During Plan / Contract or Setting Transitions

    Continuation during Plan/Contract Transitions

    Transition across contract years and treatment setting changes

    Contract year transitions: For existing members affected by negative changes, iCare will provide a transition process at the start of the new contract year and will extend transition for members enrolling with effective dates of Nov 1 or Dec 1 who need access to transition supply.effective dates Nov 1 or Dec 1 extension

    Allows continuity when formulary or rule changes are negative for the member.

    Treatment setting changes: When a member changes treatment settings during the plan year (examples: hospital ↔ home, skilled nursing transfers, stopping Part A coverage so Part D applies), iCare will cover up to a 31-day supply at a pharmacy; if changes occur more than once in the same month, an exception or prior authorization may be required and iCare will review whether changing the treatment plan would harm the member.31 days

    Provider Responsibilities and Authorization Rules

    Prior Authorization

    Prior authorization required for non-formulary or restricted drugs — transition supply is temporary

    If the drug is not on iCare’s approved list or is subject to limits, step therapy, or safety checks, the provider must submit a prior authorization or exception request; a transition supply is temporary while that prior authorization/exception is reviewed.

    • Transition supply provided temporarily while PA/exception is reviewed.
    • Prior authorization required for drugs not on formulary or those with quantity limits, step therapy, or clinical-safety criteria.
    Note

    No other prior authorization requirements specified

    There are no additional prior authorization requirements stated in the cited sections beyond those applying to non‑formulary, limited, step‑therapy, or safety‑checked drugs.

    Step Therapy and Exception Process

    SituationPolicy statement
    Step therapy applies (member required to try a less costly drug first)
    If step therapy applies, iCare may provide a temporary transition supply while the step therapy requirement is evaluated or while the member/ provider pursues an exception or prior authorization.

    Quantity Limits for Transition Supplies

    Quantity limits for transition supplies
    Applies toAny Medicare Part D drug
    Standard transition supply amount30-day supply during the first 90 days of membership (one time per drug; multiple partial fills allowed to total 30 days)
    Long-term care / treatment-setting change amount31-day supply when new member in long-term care with Medicare and full Medicaid, or up to 31 days when changing treatment settings (pharmacy), multiple partial fills allowed to total 31 days)
    When allowedDuring the first 90 days for new members (standard and LTC rules) or when changing treatment settings during the plan year
    Notes on multiple fillsIf prescription is written for less than the full allowed supply, iCare will permit multiple fills to provide up to the total 30- or 31-day supply as applicable

    Where Transition Supplies Are Obtained

    Note

    Transition supply at pharmacy after changing treatment settings

    When drugs are obtained at a pharmacy after a change in treatment setting (for example hospital↔home, skilled nursing facility transfers, or shifts affecting Part A/B vs Part D coverage), iCare will cover up to a 31‑day transition supply at the pharmacy.

    • If the member changes treatment settings more than once in the same month, an exception or prior authorization may be required.
    • iCare will review treatment plans to determine whether changing the regimen would harm the member.

    Definitions and Member Services

    Transition supply definition and related member services
    Transition supply — definitionTemporary supply of a drug a member was receiving that is allowed for a limited period while coverage or authorization is determined
    PurposeAllows members to continue critical medications temporarily while prior authorization, formulary exception, or appeals are processed
    LimitationsNot available for drugs requiring Part A/B vs Part D coverage determination, drugs potentially ineligible for Part D until indication is known, or drugs needing additional information to confirm safe use
    Auxiliary aids & language services — availabilityFree language assistance, auxiliary aids, and alternate format services are available to members; call 1-800-777-4376 (TTY: 711)
    Notice locationNotice of availability for auxiliary aids and services is posted at www.icarehealthplan.org

    Background and Policy Scope

    The purpose of a transition supply is to maintain continuity of therapy while iCare reviews coverage, prior authorization, or exception requests that could otherwise interrupt a member’s medication at enrollment or during plan changes. When a drug is not on the plan’s approved list or requires additional review for limits, step therapy, or clinical information, iCare will provide a temporary supply so the member can continue therapy while the determination is made.

    Transition supplies apply for several member situations: for new members during the initial enrollment period, for members moving between treatment settings (for example hospital to home or skilled nursing transfers), and for members affected by contract-year formulary changes. Standard transition fills are time-limited and intended only to bridge therapy until formal coverage or authorization decisions are completed.

    Policy Summary
    PayerIntegrated Home Care Services (iCare)
    Policy2026 Transition Policy for iCare Prescription Drug Coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2026
    Next Review DateN/A
    Key ActionSubmit clinical documentation or a letter explaining medical necessity when requesting an exception or prior authorization for transition supplies.
    SourceLink
    On This Page
    Transition Supply Coverage CriteriaInitial Transition Fills for New MembersContinuation During Plan / Contract or Setting TransitionsProvider Responsibilities and Authorization RulesStep Therapy and Exception ProcessQuantity Limits for Transition SuppliesWhere Transition Supplies Are ObtainedDefinitions and Member ServicesBackground and Policy Scope
    Step Therapy

    Step therapy does not block a temporary transition supply

    When step therapy applies, providers may obtain a transition supply while the member’s requirement to try a less costly drug or an exception is evaluated; the transition supply is temporary pending completion of step‑therapy review or exception/PA.

    • Step‑therapy situations include when the member must try a less costly alternative before the requested drug is approved.
    • Transition supply covers short‑term continuity while an exception or PA for step therapy is pursued.
    Note

    No additional step therapy requirements specified

    No step therapy requirements beyond the general statement that step therapy may apply are specified in these chunks.

    Documentation Required

    Submit clinical documentation or letter of medical necessity for exceptions/PA

    To request an exception or support prior authorization, the provider must submit clinical information or a letter of medical necessity explaining why covered alternatives would not work or would harm the member; iCare generally decides within 72 hours, or 24 hours for expedited (urgent) requests.

    • Letter must state the drug is needed because covered drugs would not work or would harm the member.
    • iCare must notify decision within 72 hours for standard requests and within 24 hours for expedited requests.
    Note

    Reference online notice for auxiliary aids and language services

    Providers may refer to iCare’s online Notice of Availability for auxiliary aids and services; free language assistance, auxiliary aids, and alternate format services are available at 1‑800‑777‑4376 (TTY: 711) and the notice is posted at www.icarehealthplan.org.

    • Call 1‑800‑777‑4376 (TTY: 711) for language or auxiliary aid services.
    • Notice available at www.icarehealthplan.org.
    Denial Risk

    Conditions that can lead to denial of a transition supply

    Transition supply may be denied if the drug cannot be covered as a Part D drug (e.g., needs Part A/B vs Part D determination or may be ineligible for Part D), if it is not on iCare’s approved list, or if required clinical information to confirm safe use or coverage is not provided.

    • Denial triggers include drugs requiring Part A/B versus Part D coverage determination or drugs potentially ineligible for Part D.
    • Denial may occur when clinical information needed to determine safe use or coverage is missing.
    Note

    No additional denial triggers specified in these chunks

    The cited auxiliary‑aid notice chunks do not list any separate denial triggers beyond the coverage and clinical‑information conditions already specified elsewhere.

    Auxiliary aids and language services
    Primary contactCall 1-800-777-4376 (TTY: 711) for free language assistance, auxiliary aids, and alternate format services
    Types of servicesFree language interpretation, auxiliary aids (e.g., assistive listening), and documents in alternate formats are provided
    Multilingual supportNotice and translations available in multiple languages as shown in the Auxiliary Aids and Services Notice
    Online noticeThe Auxiliary Aids and Services Notice is available at www.icarehealthplan.org